We have so far only found elevated RUNX3 and REG1A at the transcriptional level in the kidney and subsequent collection of kidney tissue from DKD patients for immunohistochemistry and protein immunoblotting is required. This evidence concerns the gene REG1A and diabetic kidney disease.